Lupin Limited (NSE:LUPIN)
India · Delayed Price · Currency is INR 1,961.60
-19.30 (-0.97%)
Oct 16, 2026, 3:28 PM IST
Lupin Market Cap
Lupin has a market cap or net worth of 894.26 billion as of October 16, 2026. Its market cap has increased by 0.89% in one year.
Market Cap
894.26B
Enterprise Value
882.13B
Revenue
299.67B
Global Rank
n/a
Country Rank
n/a
PE Ratio
16.17
ChartMarket Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 894.26B, an increase of 89,492.80%. That is a compound annual growth rate of 28.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 894.26B | -7.31% |
| Dec 31, 2025 | 964.76B | -10.05% |
| Dec 31, 2024 | 1.07T | 78.05% |
| Dec 29, 2023 | 602.42B | 80.75% |
| Dec 30, 2022 | 333.29B | -22.86% |
| Dec 31, 2021 | 432.05B | -2.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zydus Lifesciences | 1.13T |
| Laurus Labs | 1.11T |
| Cipla | 1.07T |
| Aurobindo Pharma | 958.98B |
| Mankind Pharma | 951.71B |
| Glenmark Pharmaceuticals | 632.98B |
| Alkem Laboratories | 608.41B |
| Gland Pharma | 497.51B |